HCA Holdings, Inc. (NYSE:HCA) saw some unusual options trading activity on Thursday. Stock traders purchased 9,836 call options on the company. This represents an increase of 1,863% compared to the typical volume of 501 call options.
Shares of HCA (NYSE:HCA) opened at $87.59 on Thursday. The firm has a market cap of $30,607.84, a P/E ratio of 13.12, a PEG ratio of 1.27 and a beta of 0.56. The company has a debt-to-equity ratio of -6.46, a quick ratio of 1.41 and a current ratio of 1.68. HCA has a fifty-two week low of $71.18 and a fifty-two week high of $91.03.
HCA (NYSE:HCA) last posted its quarterly earnings data on Tuesday, October 31st. The company reported $1.21 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $1.21. The company had revenue of $10.70 billion during the quarter, compared to analyst estimates of $10.70 billion. HCA had a net margin of 6.13% and a negative return on equity of 47.16%. The company’s revenue was up 4.1% on a year-over-year basis. During the same quarter last year, the business posted $1.45 earnings per share. equities research analysts forecast that HCA will post 6.56 EPS for the current year.
In related news, insider Michael S. Cuffe sold 2,150 shares of the stock in a transaction dated Wednesday, November 22nd. The shares were sold at an average price of $78.00, for a total value of $167,700.00. Following the completion of the sale, the insider now owns 12,476 shares in the company, valued at $973,128. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, SVP Victor L. Campbell sold 8,000 shares of the stock in a transaction dated Wednesday, November 8th. The shares were sold at an average price of $78.00, for a total transaction of $624,000.00. Following the completion of the sale, the senior vice president now owns 127,275 shares of the company’s stock, valued at approximately $9,927,450. The disclosure for this sale can be found here. Insiders have sold 22,450 shares of company stock valued at $1,737,681 over the last 90 days. Corporate insiders own 2.90% of the company’s stock.
Several hedge funds and other institutional investors have recently bought and sold shares of HCA. Northwestern Mutual Wealth Management Co. increased its holdings in shares of HCA by 14.0% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 1,163 shares of the company’s stock worth $101,000 after buying an additional 143 shares in the last quarter. Bronfman E.L. Rothschild L.P. increased its holdings in shares of HCA by 35.1% in the second quarter. Bronfman E.L. Rothschild L.P. now owns 1,232 shares of the company’s stock valued at $107,000 after purchasing an additional 320 shares in the last quarter. Atlantic Trust LLC acquired a new stake in shares of HCA in the second quarter valued at approximately $118,000. Lee Financial Co acquired a new stake in shares of HCA in the second quarter valued at approximately $125,000. Finally, Acrospire Investment Management LLC increased its holdings in shares of HCA by 14.3% in the second quarter. Acrospire Investment Management LLC now owns 1,600 shares of the company’s stock valued at $140,000 after purchasing an additional 200 shares in the last quarter. 75.35% of the stock is owned by institutional investors.
Several equities research analysts recently weighed in on the stock. Citigroup upgraded shares of HCA from a “neutral” rating to a “buy” rating in a research note on Tuesday. Robert W. Baird reiterated a “buy” rating on shares of HCA in a research note on Thursday, September 28th. ValuEngine upgraded shares of HCA from a “hold” rating to a “buy” rating in a research note on Monday, October 2nd. BMO Capital Markets assumed coverage on shares of HCA in a research report on Monday, October 16th. They issued an “outperform” rating and a $90.00 price target for the company. Finally, Royal Bank of Canada reissued an “outperform” rating and issued a $90.00 price target on shares of HCA in a research report on Thursday, October 19th. Two analysts have rated the stock with a sell rating, five have given a hold rating and nineteen have issued a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average target price of $90.20.
ILLEGAL ACTIVITY NOTICE: This piece of content was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this piece of content on another publication, it was illegally stolen and reposted in violation of U.S. & international copyright and trademark law. The correct version of this piece of content can be accessed at https://www.dispatchtribunal.com/2017/12/14/hca-sees-unusually-high-options-volume-hca.html.
HCA Company Profile
HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.
Receive News & Ratings for HCA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA and related companies with MarketBeat.com's FREE daily email newsletter.